SEC Tracker
Get the app

Merck MRK

Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Announces exit or restructuring costs (2.05)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Merck files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  2. Amgen AMGN public float $150.1B, Jun 30, 2025
  3. Pfizer PFE public float $138.0B, Jun 29, 2025
  4. AbbVie ABBV public float $325.1B, Jun 30, 2025
  5. Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025